Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-2.86 Mil
% of Total Estimate Gain
-27.13%

Affinity Asset Advisors, LLC's Arrowhead Pharmaceuticals Inc Holding Summary

As of 2025-03-31, Affinity Asset Advisors, LLC held - shares of Arrowhead Pharmaceuticals Inc(ARWR), totaling N/A. This investment constitutes 0% of their stock portfolio, and Affinity Asset Advisors, LLC now holds 0% of the outstanding Arrowhead Pharmaceuticals Inc(ARWR) stock.

The initial trade took place in 2024Q1. And since then Affinity Asset Advisors, LLC has made 2 purchases of ARWR, at an average price of $26.71, for a total of 395,000.00 shares. In addition, there have been 3 sales at an average price of $19.47 for 395,000.00 shares. Based on historical transaction data and ARWR's current price of $16.63, Affinity Asset Advisors, LLC's estimated gain on his ARWR holdings is $-2.86 Mil, reflecting a -27.13% gain to date.

Affinity Asset Advisors, LLC ARWR ($16.63) Holding Chart

Affinity Asset Advisors, LLC ARWR ($16.63) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1